Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Rank in Stocks #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Share Price
$1.02
Market Cap
$131.45M
Change (1 day)
-0.62%
Change (1 year)
-37.92%
Country
TW
Trade Pharmosa Biopharm Inc. (6875)

Category

Stock price history for Pharmosa Biopharm Inc. (6875)
Highest end of day price: $1.04 on 2026-08-01

Lowest end of day price: $1.60 on 2022-02-01
Stock price history of Pharmosa Biopharm Inc. from 2022 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$764.47 8.17%
CH